December 18, 2025 03:00 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian Visa Application Centre in Dhaka shuts down early amid rising security concerns | Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell | ‘Won’t apologise’: Prithviraj Chavan stands firm on controversial Operation Sindoor remark despite backlash | India summons Bangladesh High Commissioner after provocative 'seven sisters' remark | Amazon eyes $10 billion investment in OpenAI — a gamechanger for AI industry! | Goa nightclub fire horror: Luthra brothers brought back to India from Thailand, arrested | Messi chaos costs minister his job: Aroop Biswas resigns after Salt Lake Stadium fiasco | Bengal SIR draft list out: Around 58 lakh voters’ names dropped | Relief for Sonia, Rahul Gandhi as Delhi court refuses to act on ED chargesheet in National Herald case | Centre moves to replace MGNREGA with 'G Ram G', sets stage for winter session showdown
Image Credit : Photo: File/UNI

Govt asks Patanjali to explain ‘dubious’ transactions flagged by economic intelligence wing

| @indiablooms | May 30, 2025, at 05:10 pm

New Delhi: India’s Corporate Affairs Ministry has issued a notice to Patanjali Ayurved Ltd., the traditional medicine firm co-founded by yoga guru Baba Ramdev, seeking clarification over transactions considered suspicious, Bloomberg reported, citing people familiar with the matter.

The notice followed findings by the federal economic intelligence wing, which identified the transactions as “abnormal and dubious”, the people said, requesting anonymity due to regulatory protocols.

The individuals did not reveal the financial scale of the transactions, noting that the investigation remains at a preliminary stage.

According to them, the company has been granted approximately two months to submit a response.

Authorities will also probe potential breaches of corporate governance and possible diversion of funds, they added.

The Corporate Affairs Ministry did not immediately respond to a request for comment. Patanjali Ayurved has also yet to provide a statement.

This is not the first instance of regulatory scrutiny for Patanjali Ayurved or its subsidiaries.

Last year, one of its units was served show-cause notices by the government over alleged tax defaults and ineligible refund claims.

Separately, India’s Supreme Court barred the company from advertising its products as cures for illnesses such as cancer, citing violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

In February 2025, Kerala’s Drugs Control Department reported 26 active cases across different courts in the state against Ramdev and Patanjali under the same advertisement law.

Several newspapers are also facing legal action for publishing the contentious ads.

While Patanjali Ayurved remains privately held, its listed arm, Patanjali Foods Ltd., has seen its shares fall nearly 10% so far this month.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm